Medpace (MEDP) General Counsel exercises options and sells 16,349 shares at $450

Rhea-AI Filing Summary

Medpace Holdings, Inc. General Counsel & Corporate Secretary Stephen P. Ewald reported an exercise-and-sell transaction in company stock. He exercised options covering 16,349 shares of common stock at $138.87 per share and sold 16,349 shares in an open-market sale at $450.00 per share pursuant to a limit order placed during an open window period. Following these transactions, he holds 20,343 common shares directly.

Insights

Equity compensation & insider-trading analyst

Routine option exercise funded by same-day share sale under a limit order.

Stephen P. Ewald, General Counsel of Medpace Holdings, Inc., exercised employee stock options for 16,349 shares at an exercise price of $138.87 and sold 16,349 common shares at $450.00 each on the same date.

This pattern reflects an exercise-and-sell transaction, where the insider converts options into shares, then disposes of an equivalent number of shares, effectively monetizing option value rather than increasing equity exposure. The underlying option, which vested in full on February 15, 2026, is now fully exercised with no remaining derivative position from this grant.

A footnote explains the sale was executed under a limit order during an open window period, suggesting a structured, policy-compliant trade rather than an opportunistic move. After the transactions, Ewald continues to own 20,343 common shares directly, indicating he retains a meaningful ongoing stake.

Insider Trade Summary

Net Seller: 16,349 shares ($7,357,050)

Net Sell 3 txns

Insider EWALD STEPHEN P

Role General Counsel & Corp. Secy.

Sold 16,349 shs ($7.36M)

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	16,349	$0.00	--
Exercise	Common Stock	16,349	$138.87	$2.27M
Sale	Common Stock	16,349	$450.00	$7.36M

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct, null); Common Stock — 36,692 shares (Direct, null)

Footnotes (1)

1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. The option vested in full on February 15, 2026.

Key Figures

Shares sold: 16,349 shares Sale price: $450.00 per share Options exercised: 16,349 shares +3 more

6 metrics

Shares sold 16,349 shares Open-market sale of common stock on May 28, 2026

Sale price $450.00 per share Price for Medpace common stock sold

Options exercised 16,349 shares Employee stock option exercise on May 28, 2026

Exercise price $138.87 per share Exercise price of employee stock option

Shares owned after 20,343 shares Direct Medpace common stock holdings post-transaction

Option expiration August 15, 2027 Original expiration date of exercised option grant

Key Terms

limit order, open window period, Employee Stock Option (Right to Buy), derivative security

4 terms

limit order financial

"transactions were effected pursuant to a limit order placed by the Reporting Person"

A limit order is an instruction to buy or sell a stock only at a specific price or better, giving you control over the exact price you pay or receive. It matters to investors because it acts like a price guard—similar to setting a maximum you’ll pay for an item at a store—so you avoid unexpected prices, though the trade may not happen if the market never reaches your limit.

open window period regulatory

"limit order placed by the Reporting Person during an open window period"

Employee Stock Option (Right to Buy) financial

"security_title": "Employee Stock Option (Right to Buy)""

derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

EWALD STEPHEN P

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS,INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OHIO 45227

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel & Corp. Secy.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		M		16,349	A	$138.87	36,692	D
Common Stock	05/28/2026		S(1)		16,349	D	$450	20,343	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$138.87	05/28/2026		M			16,349	(2)	08/15/2027	Common Stock	16,349	$0	0	D

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.

2. The option vested in full on February 15, 2026.

Remarks:

	/s/ Stephen P. Ewald	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Medpace (MEDP) General Counsel Stephen P. Ewald report?

Stephen P. Ewald reported exercising options for 16,349 Medpace common shares and selling 16,349 shares in an open-market transaction. The activity occurred on May 28, 2026 and reflects an exercise-and-sell pattern rather than a net increase in equity exposure.

How many Medpace (MEDP) shares did Stephen P. Ewald sell and at what price?

He sold 16,349 shares of Medpace common stock at a price of $450.00 per share in an open-market sale. The sale was executed pursuant to a limit order placed during an open window trading period allowed by company policy.

What was the option exercise price in Stephen P. Ewald’s Medpace (MEDP) Form 4 filing?

Ewald exercised employee stock options covering 16,349 shares at an exercise price of $138.87 per share. These options were identified as an “Employee Stock Option (Right to Buy)” and had vested in full on February 15, 2026 before the reported transaction date.

How many Medpace (MEDP) shares does Stephen P. Ewald own after the reported transactions?

Following the May 28, 2026 transactions, Stephen P. Ewald directly owns 20,343 shares of Medpace common stock. This post-transaction holding reflects his remaining equity stake after exercising options and selling 16,349 shares in the open market on the same date.

Were Stephen P. Ewald’s Medpace (MEDP) share sales under a trading plan or limit order?

The filing notes that the transactions were effected pursuant to a limit order placed by Stephen P. Ewald during an open window period. This indicates the trades followed pre-set price instructions and complied with the company’s permitted trading window policies.

What happened to the employee stock option in the Medpace (MEDP) Form 4 for Stephen P. Ewald?

The employee stock option for 16,349 shares, with a $138.87 exercise price and August 15, 2027 expiration, was fully exercised. After the exercise on May 28, 2026, the derivative position shows zero remaining, meaning this specific option grant has been completely converted into common shares.